Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03176303 · ClinicalTrials.gov registry record
Study Using the SpinalStim Device Following Lumbar Fusion Surgery
A clinical trial, sponsored by Orthofix.
- Completed
- Registry status
- 206
- Enrollment target
NCT03176303 is a clinical trial that has completed, run by Orthofix. The registered enrollment target is 206 participants.
The verdict
NCT03176303 has completed, sponsored by Orthofix.
- COMPLETED
- Registry status
- 206 participants
- Enrollment target
Study Summary
This study examines the effect of adjunctive use of the SpinalStim bone growth stimulator on lumbar fusion rate in high risk subjects who have had lumbar fusion surgery. All participants will wear the bone growth stimulator for a minimum of 2 hours/day for 6 months.
Interventions
- DEVICE SpinalStim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2017-06-28 |
| Est. Completion | 2021-07-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03176303
The ClinicalTrials.gov registry entry for NCT03176303 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Orthofix, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SpinalStim is the first listed.
NCT03176303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03176303 about?
NCT03176303 is a clinical study titled "Study Using the SpinalStim Device Following Lumbar Fusion Surgery". This study examines the effect of adjunctive use of the SpinalStim bone growth stimulator on lumbar fusion rate in high risk subjects who have had lumbar fusion surgery. All participants will wear the bone growth stimulator for a minimum of 2 hours/day for 6 months.
What is the current status of trial NCT03176303?
This trial is currently completed. The enrollment target is 206 participants. The study started on 2017-06-28. Estimated completion is 2021-07-12.
What interventions are being tested in trial NCT03176303?
The interventions under investigation include: SpinalStim (DEVICE).
Who is sponsoring clinical trial NCT03176303?
This trial is sponsored by Orthofix, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.